ISO 15223-1:2021/Amd 1:2025 PDF

Overview

ISO 15223-1:2021/Amd 1:2025 is an important international amendment to the ISO 15223-1:2021 standard, focusing on medical devices and the symbols used in manufacturer-supplied information. This amendment introduces a defined term for the "authorized representative" and modifies the EC REP symbol to ensure it is not restricted to any specific country or region. Developed by the International Organization for Standardization (ISO), this update supports clear and consistent global communication for medical device information, contributing to enhanced regulatory compliance and user safety.

Key Topics

• Authorized Representative Definition The amendment adds a formal definition for the authorized representative as a natural or legal person established within a country or jurisdiction who has a written mandate from the manufacturer to act on their behalf regarding obligations under local legislation. This terminology aligns with ISO 13485:2016 to clarify roles in regulatory processes.

• Modified EC REP Symbol The updated EC REP symbol no longer bears country- or region-specific markers, reflecting the need for standardized identification that transcends borders. The symbol now includes flexibility by allowing replacement text with two- or three-letter country codes as defined by ISO standards (e.g., ISO 3166-1), enhancing worldwide applicability.

• Symbol Usage and Labeling Requirements Manufacturers must display the authorized representative symbol accompanied by the name and address of the representative. Multiple responsible entities can consolidate their symbols alongside a shared address to avoid duplication. This ensures transparent traceability and compliance with various national requirements.

• Referenced Guidelines The amendment integrates cross-references to related ISO standards such as ISO 20417 and the ISO 18113 series, which provide additional guidance on labeling, translation, and repackaging of medical device information.

Applications

This amendment is critical for:

• Medical Device Manufacturers Facilitating clear communication and compliance by using globally harmonized symbols for authorized representatives, simplifying logistic and legal responsibilities in multiple jurisdictions.

• Regulatory Bodies and Inspectors Improving clarity in identifying authorized representatives on medical device labels, which supports regulatory assessments and market surveillance activities.

• Authorized Representatives and Distributors Ensuring their roles and responsibilities are clearly identified and traceable on product information, aiding accountability and customer confidence.

• Healthcare Providers and End Users Enhancing the comprehension of product labeling by standardized symbols, reducing misinterpretations and improving safety.

This amendment ensures that medical devices marketed internationally display standardized, recognizable symbols that comply with national and international regulatory requirements, thus facilitating smoother market access and regulatory oversight.

Related Standards

• ISO 15223 Series Governs symbols used with medical device information, with Part 1 covering general requirements and symbol definitions.

• ISO 13485:2016 Specifies requirements for quality management systems where an organization needs to demonstrate the ability to provide medical devices and related services.

• ISO 20417 Provides requirements for information supplied by the manufacturer of medical devices.

• ISO 18113 Series (Parts 1 to 5) Details requirements and guidance on information supplied by the manufacturer for medical devices, including translation and repackaging.

• ISO 3166-1 Defines country codes used internationally for addressing and symbol labeling purposes.

This amendment to ISO 15223-1 supports manufacturers and regulatory stakeholders by clarifying terminology and updating symbols for better global uniformity. Using authorized representative symbols correctly ensures compliance, improves information clarity, and supports effective risk management in healthcare environments worldwide.